We have both the experts and facilities to accommodate your research and development (R&D) needs.
When you partner with us, you'll work with people who are leaders in their fields, and have the ability to solve some of the greatest challenges faced by industry, businesses and government.
You'll also have access to our state-of-the-art equipment and facilities.
Our competitive rates ensure your organisation maximises R&D budgets, and allows you to claim the R&D tax incentive. We can scope projects according to your budget without the need to hire or retain costly full-time staff. We also have access to government funding and grants, which can increase your research budget.
H2Potential is Australasia's first scientist-led company completely focused on Hydrogen, with deep expertise in :
- Solving technical challenges
- Implementing new applications
- Optimising and training on existing processes
- Evaluating emerging technologies and companies
-Helping companies move to higher TRL and scale-up
Find out more today
The BHP Foundation has partnered with the University of Sydney’s Brain and Mind Centre to change the way local communities in Australia invest in youth mental health and social care.
The five-year program, commencing in 2021 ‘Right care, first time, where you live,’ will harness latest advances in systems modelling and simulation to guide national and local investments in sustained, coordinated and digitally enhanced youth mental health care.
The University of Sydney is working with three other universities to establish the Sydney Quantum Academy, helping to ensure that cutting-edge quantum research translates into a sustainable industry and jobs.
It the initiative of Macquarie University, UNSW Sydney, the University of Sydney and University of Technology Sydney and has funding support from the NSW Government. It will help train the next generation of engineers and scientists in quantum computing, cementing Sydney’s place as the leading global city for quantum technology and ensuring NSW is a world centre for jobs in the emerging quantum economy.
The Key Centre for Polymers and Colloids (KCPC) has recently licensed magnetic nanoparticle stabilisation technology to the University of South Australia spin off company, Ferronova P/L.
Ferronova has now received approval to use this technology in “first in human” trials at the Royal Adelaide Hospital, for sentinel lymph node detection in oral cancer patients.
These magnetic nanoparticles have already demonstrated better performance for this application compared to the current commercialised product in preclinical mouse and pig model studies over the past 3 years. If these trials are successful, they could offer vastly improved health outcomes for a wide range of cancer sufferers.
Our multi-year partnership with Microsoft establishes ongoing investment at Sydney’s Nanoscience Hub as Microsoft moves from research to real-world engineering of quantum machines. Professor David Reilly from the University School of Physics is leading the team at Station Q and believes that this partnership will bring quantum computing out of the laboratory and into the real world where it can have genuine impact.
Professor Benjamin Eggleton will join forces with Australia’s Defence Science and Technology Group and American technology company and defence contractor Harris Corporation.
The $540,000 project will develop advanced technologies to enhance satellite communications, radar systems and surveillance capabilities for defence, as well as lay the groundwork for future fifth-generation wireless communications.
A network of dementia researchers, clinicians and carers collaboratively working towards reducing the burden of dementia within NSW.
The network includes collaborations with key researchers, clinicians, health organisations and government bodies to discuss current research efforts, the future of dementia in NSW and workshop how to improve outcomes. Below are some of our collaborations, events and initiatives from the Network so far.
The Psycho-oncology Cooperative Research Group (PoCoG) is a member of the Co-operative Clinical Trials Groups of the Clinical Oncological Society of Australia and receives core infrastructure funding from the Australian federal government through Cancer Australia.
The PoCoG executive office is located in the School of Psychology at the University of Sydney. Membership is open to researchers and health professionals from Australia and New Zealand, and associate membership is open to international psycho-oncology researchers and health professionals.